지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2021.1
- 수록면
- 479 - 486 (8page)
이용수
초록· 키워드
오류제보하기
Purpose: The aim of this study was to evaluate the episodes of febrile neutropenia (FN) in patients with gastric cancer (GC),colorectal cancer (CRC), lung cancer (LC), and breast cancer (BC); and to identify the incidence and trends of admission rates, aswell as factors affecting mortality. Materials and Methods: Using nationwide claims data, all new admissions to hospitals for FN were selected. We evaluated theincidence of FN and mortality-related clinical factors in adult cancer patients who received cytotoxic chemotherapy from January2004 to December 2013. Results: While the incidence of FN increased, the length of hospitalization decreased in Korea. The incidence of FN was 19.8% inLC patients, 15.5% in GC patients, 13.3% in BC patients, and 9.5% in CRC patients. The overall in-hospital mortality of FN was12.9% and showed a decreasing trend. Admission rates to intensive care units and in-hospital mortality were the highest for lungcancer (15.2% and 19.3%, respectively). Age and sepsis syndrome were risk factors for in-hospital mortality for all cancer types. Conclusion: Careful observation and active prophylaxis should be considered for patients at high risk of FN.
목차
등록된 정보가 없습니다.
참고문헌 (20)
참고문헌 신청
홍세리 / 2020 / Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2017 / Cancer Research and Treatment 52(2):335~350
Freifeld AG / 2011 / Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer : 2010 update by the Infectious Diseases Society of America / Clin Infect Dis 52:e56~93
Dale DC / 2003 / Myelotoxicity and dose intensity of chemotherapy : reporting practices from randomized clinical trials / J Natl Compr Canc Netw 1:440~454
Schilling MB / 2011 / Costs and outcomes associated with hospitalized cancer patients with neutropenic complications : a retrospective study / Exp Ther Med 2:859~866
Caggiano V / 2005 / Incidence, cost, and mortality of neutropenia hospitalization associated with chemotherapy / Cancer 103:1916~1924
Freifeld AG / 2011 / Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer : 2010 update by the Infectious Diseases Society of America / Clin Infect Dis 52:e56~93
Dale DC / 2003 / Myelotoxicity and dose intensity of chemotherapy : reporting practices from randomized clinical trials / J Natl Compr Canc Netw 1:440~454
Schilling MB / 2011 / Costs and outcomes associated with hospitalized cancer patients with neutropenic complications : a retrospective study / Exp Ther Med 2:859~866
Caggiano V / 2005 / Incidence, cost, and mortality of neutropenia hospitalization associated with chemotherapy / Cancer 103:1916~1924
함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
Incidence of Febrile Neutropenia in Advanced Breast Cancer Patients Receiving Adjuvant Docetaxel-Doxorubicin-Cyclophosphamide Chemotherapy in Korea and Its Impact on Prognosis
Journal of Breast Disease
2019 .01
-
Lesson from COVID-19 outbreak; importance of standard precautions to febrile neutropenia prevention in patients with breast cancer who received adjuvant chemotherapy: a retrospective observational study
Annals of Surgical Treatment and Research
2024 .10
-
Incidence, Risk Factors, and Outcomes of Febrile Neutropenia in Thai Hematologic Malignancy Patients Receiving Chemotherapy: A 6-year Retrospective Cohort Study
Asian Pacific journal of cancer prevention : APJCP
2015 .01
-
Berberine Suppresses Fibronectin Expression through Inhibition of c-Jun Phosphorylation in Breast Cancer Cells
Journal of Breast Cancer
2018 .01
-
Clinical utilization of long-acting granulocyte colony-stimulating factor (pegfilgrastim) prophylaxis in breast cancer patients with adjuvant docetaxel-cyclophosphamide chemotherapy
Annals of Surgical Treatment and Research
2021 .02
-
Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2014
Cancer Research and Treatment
2017 .01
-
Prediction of Cancer Incidence and Mortality in Korea, 2017
Cancer Research and Treatment
2017 .01
-
Improved Survival of Cancer Patients Admitted to the Intensive Care Unit between 2002 and 2011 at a U.S. Teaching Hospital
Cancer Research and Treatment
2019 .01
-
Prediction of Cancer Incidence and Mortality in Korea, 2021
Cancer Research and Treatment
2021 .01
-
Prediction of Cancer Incidence and Mortality in Korea, 2016
Cancer Research and Treatment
2016 .01
-
Projection of Cancer Incidence and Mortality From 2020 to 2035 in the Korean Population Aged 20 Years and Older
예방의학회지
2022 .11
-
Prediction of Cancer Incidence and Mortality in Korea, 2023
Cancer Research and Treatment
2023 .04
-
Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2013
Cancer Research and Treatment
2016 .01
-
Prediction of Cancer Incidence and Mortality in Korea, 2019
Cancer Research and Treatment
2019 .01
-
Incidence and Mortality and Epidemiology of Breast Cancer in the World
Asian Pacific journal of cancer prevention : APJCP
2016 .01
-
Prediction of Cancer Incidence and Mortality in Korea, 2022
Cancer Research and Treatment
2022 .04
-
Prediction of Cancer Incidence and Mortality in Korea, 2020
Cancer Research and Treatment
2020 .01
-
Increasing Antimicrobial Resistance Monitored in Surveillance Analysis of Blood Stream Infections in Febrile Neutropenic Pediatric Oncology Patients
Asian Pacific journal of cancer prevention : APJCP
2015 .01
-
Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2017
Cancer Research and Treatment
2020 .01
이 논문의 저자 정보
최근 본 자료
댓글(0)
0